ARTH — Arch Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $7.16m
- $13.15m
- $0.08m
Annual cashflow statement for Arch Therapeutics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.55 | -4.69 | -6.24 | -5.28 | -6.98 |
| Depreciation | |||||
| Non-Cash Items | -0.597 | 0.279 | 0.391 | 0.05 | 1.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.132 | -0.64 | -0.112 | 0.767 | 2.2 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -5.27 | -5.04 | -5.96 | -4.46 | -3.37 |
| Capital Expenditures | 0 | -0.002 | -0.003 | 0 | -0.005 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.002 | -0.003 | 0 | -0.005 |
| Financing Cash Flow Items | — | — | — | -0.589 | -0.35 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.78 | 3.83 | 7.27 | 2.94 | 2.85 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.49 | -1.22 | 1.31 | -1.52 | -0.524 |